BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 25329665)

  • 1. Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease.
    Park H; Shin JW; Park SG; Kim W
    PLoS One; 2014; 9(10):e109710. PubMed ID: 25329665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison Study of Oropharyngeal Microbiota in Case of Bronchial Asthma and Chronic Obstructive Pulmonary Disease in Different Severity Levels].
    Ogorodova LM; Fedosenko SV; Popenko AS; Petrov VA; Tyakht AV; Saltykova IV; Deev IA; Kulikov ES; Kirillova NA; Govorun VM; Kostryukova ES
    Vestn Ross Akad Med Nauk; 2015; (6):669-78. PubMed ID: 27093794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma.
    Lopes Dos Santos Santiago G; Brusselle G; Dauwe K; Deschaght P; Verhofstede C; Vaneechoutte D; Deschepper E; Jordens P; Joos G; Vaneechoutte M
    BMC Microbiol; 2017 May; 17(1):109. PubMed ID: 28486933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.
    Einarsson GG; Comer DM; McIlreavey L; Parkhill J; Ennis M; Tunney MM; Elborn JS
    Thorax; 2016 Sep; 71(9):795-803. PubMed ID: 27146202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing.
    Zakharkina T; Heinzel E; Koczulla RA; Greulich T; Rentz K; Pauling JK; Baumbach J; Herrmann M; Grünewald C; Dienemann H; von Müller L; Bals R
    PLoS One; 2013; 8(7):e68302. PubMed ID: 23874580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
    Wu Y; Luo Z; Liu C
    Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology.
    Larsen JM; Musavian HS; Butt TM; Ingvorsen C; Thysen AH; Brix S
    Immunology; 2015 Feb; 144(2):333-42. PubMed ID: 25179236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oropharyngeal microbial ecosystem perturbations influence the risk for acute respiratory infections in common variable immunodeficiency.
    Pulvirenti F; Giufrè M; Pentimalli TM; Camilli R; Milito C; Villa A; Sculco E; Cerquetti M; Pantosti A; Quinti I
    Front Immunol; 2024; 15():1371118. PubMed ID: 38873612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations.
    Huang YJ; Kim E; Cox MJ; Brodie EL; Brown R; Wiener-Kronish JP; Lynch SV
    OMICS; 2010 Feb; 14(1):9-59. PubMed ID: 20141328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.
    Knudsen KS; Lehmann S; Nielsen R; Tangedal S; Haaland I; Hiemstra PS; Eagan TM
    PLoS One; 2022; 17(1):e0262082. PubMed ID: 34990493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbation induces a microbiota shift in sputa of COPD patients.
    Jubinville E; Veillette M; Milot J; Maltais F; Comeau AM; Levesque RC; Duchaine C
    PLoS One; 2018; 13(3):e0194355. PubMed ID: 29579057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characterization of bacterial communities of oropharynx microbiota in healthy children by combining culture techniques and sequencing of the 16S rRNA gene.
    Maleki A; Zamirnasta M; Taherikalani M; Pakzad I; Mohammadi J; Krutova M; Kouhsari E; Sadeghifard N
    Microb Pathog; 2020 Jun; 143():104115. PubMed ID: 32135220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva as a non-invasive specimen for COPD assessment.
    Melo-Dias S; Valente C; Andrade L; Marques A; Sousa A
    Respir Res; 2022 Jan; 23(1):16. PubMed ID: 35093093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metagenome and Metatranscriptome Profiling of Moderate and Severe COPD Sputum in Taiwanese Han Males.
    Lee SW; Kuan CS; Wu LS; Weng JT
    PLoS One; 2016; 11(7):e0159066. PubMed ID: 27428540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.
    Hazra D; Sm F; Chawla K; Sintchenko V; Martinez E; Magazine R; Siddalingaiah N
    F1000Res; 2023; 12():528. PubMed ID: 37928173
    [No Abstract]   [Full Text] [Related]  

  • 16. The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease.
    Pragman AA; Lyu T; Baller JA; Gould TJ; Kelly RF; Reilly CS; Isaacson RE; Wendt CH
    Microbiome; 2018 Jan; 6(1):7. PubMed ID: 29316977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity of Fungi and Bacteria in Bronchoalveolar Lavage Fluid during Development of Chronic Obstructive Pulmonary Disease.
    Wu X; Wei X; Li X; Deng J; Zhang J
    Jpn J Infect Dis; 2022 Nov; 75(6):560-568. PubMed ID: 35908874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic cigarette smoke exposure and pneumococcal infection induce oropharyngeal microbiota dysbiosis and contribute to long-lasting lung damage in mice.
    Hilty M; Wüthrich TM; Godel A; Adelfio R; Aebi S; Burgener SS; Illgen-Wilcke B; Benarafa C
    Microb Genom; 2020 Dec; 6(12):. PubMed ID: 33295863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alterations of oral, airway and intestine microbiota in chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Kou Z; Liu K; Qiao Z; Wang Y; Li Y; Li Y; Yu X; Han W
    Front Immunol; 2024; 15():1407439. PubMed ID: 38779669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper Respiratory Dysbiosis with a Facultative-dominated Ecotype in Advanced Lung Disease and Dynamic Change after Lung Transplant.
    Simon-Soro A; Sohn MB; McGinniss JE; Imai I; Brown MC; Knecht VR; Bailey A; Clarke EL; Cantu E; Li H; Bittinger K; Diamond JM; Christie JD; Bushman FD; Collman RG
    Ann Am Thorac Soc; 2019 Nov; 16(11):1383-1391. PubMed ID: 31415219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.